Search the Newsreel

Andersons Inc (ANDE) (Q2 2026) Earnings Call Highlights: Record Renewables Performance Drives ...

This article first appeared on GuruFocus. Adjusted EPS: $2.15 per diluted share for Q2 2026, compared to $0.24 in Q2 2025. Net Income: $57 million, or $1.65 per diluted share, for Q2 2026. Adjusted Net Income: $74 million for Q2 2026. Adjusted EBITDA: $140 …

Director Thomas Chorman sells 50 Standex (SXI) shares in 10b5-1 trade

Standex International director Thomas E. Chorman sold 50 shares of common stock on August 3, 2026, at $305.56 per share, under a Rule 10b5-1 trading plan. Following this transaction, he directly holds 12,366 shares of SXI. The sale is categorized as an open-market or …

DA Davidson raises Standex International price target on growth outlook

DA Davidson has increased its price target for Standex International (NYSE:SXI) to $350 from $323, maintaining a Buy rating after the company reported strong fourth-quarter fiscal 2026 earnings. Standex International achieved 7.7% organic growth, and DA Davidson anticipates double-digit organic growth for at least …

Andersons (NASDAQ:ANDE) Shares Gap Up After Better-Than-Expected Earnings

Andersons Q2 Earnings Call Highlights

This article first appeared on GuruFocus. Adjusted EPS: $2.15 per diluted share for Q2 2026, compared to $0.24 in Q2 2025. Net Income: $57 million, or $1.65 per diluted share, for Q2 2026. Adjusted Net Income: $74 million for Q2 2026. Adjusted EBITDA: $140 …

Agribusiness, Renewables boost earnings for The Andersons

The Andersons reported significantly increased earnings in the second quarter, driven by strong performance in its Agribusiness and Renewables segments. Net income rose to $56.6 million from $7.9 million a year ago, with Renewables delivering exceptional results due to strong operational execution and merchandising, …

Earnings call transcript: The Andersons beats Q2 2026 profit view as stock rises

The Andersons Inc. reported strong second-quarter 2026 results, with adjusted earnings per share of $2.15 significantly beating Wall Street estimates, despite revenue of $3.1 billion falling short of forecasts. The agricultural and renewables company saw its stock rise 5.21% in premarket trading due to …

First Trust Advisors LP Takes Position in Tandem Diabetes Care, Inc. $TNDM

First Trust Advisors LP has acquired a new stake in Tandem Diabetes Care, Inc. (NASDAQ:TNDM), purchasing 342,707 shares valued at approximately $6.57 million during the first quarter. Other institutional investors also adjusted their holdings in the medical device company. Tandem Diabetes Care reported better-than-expected …

Andersons stock price target maintained at $110 by Texas Capital

Texas Capital Securities has maintained a Buy rating and a $110 price target for The Andersons (NASDAQ:ANDE) due to strong quarterly performance, particularly in its Renewables segment. The company's adjusted EPS significantly beat consensus estimates, contributing to a 105% return over the past year. …

Banco Santander (NYSE:SAN) - Stock Analysis

This article provides a detailed stock analysis of Banco Santander (NYSE:SAN), highlighting its current valuation, future growth prospects, past performance, financial health, and dividend information. It notes that SAN is trading below its estimated fair value and forecasts annual earnings growth of 15.41%. The …

The Sandesh Share Price Outlook: Where It Could Be in 3 Years

Is loanDepot Inc (LDI) Positioned for Growth After Q2 Earnings?

LoanDepot: Q2 Earnings Snapshot

Andersons (ANDE) Stock Rallies As Renewables Earnings Reset The Story

Tandem Diabetes Earnings: What To Look For From TNDM

The Andersons reports Q2 net income of $57M, driven by record renewables production and improved agribusiness margins.

The Andersons, Inc. announced a strong second quarter for 2026, achieving a net income of $57 million and an adjusted net income of $74 million. This performance was primarily driven by record production and merchandising in its Renewables segment, alongside improved margins in the …

Segall Bryant & Hamill LLC Trims Holdings in Standex International Corporation $SXI

Segall Bryant & Hamill LLC reduced its stake in Standex International Corporation (NYSE:SXI) by 9.5% in the first quarter, selling 7,995 shares but retaining 75,918 shares valued at approximately $19.35 million. Despite this, institutional investors collectively own 90.35% of the company. Standex International reported …

Candel Therapeutics to present prostate cancer data at ASTRO By Investing.com

Candel Therapeutics Inc. (NASDAQ:CADL) will present data on its aglatimagene besadenovec immunotherapy for localized prostate cancer at the 2026 American Society for Radiation Oncology Annual Meeting. The presentation will detail how quantitative digital pathology defines immune activation following the treatment. Aglatimagene besadenovec, Candel's lead …

KBDC Rallies to $13.67: Kayne Anderson BDC Gains 2.78% as Support Holds - AD Line Divergence

ALEXANDERS INC 2Q 2026: Revenue $54.7M, EPS $30.24— 10-Q Summary

ALEXANDERS INC (ALX) reported strong second-quarter 2026 results, with revenue of $54.7 million and diluted EPS of $30.24, significantly up from the prior year. This increase was primarily driven by a $148.0 million gain from the sale of its Rego Park I property. The …

The Andersons Q2 net income rises to $56.6 million

The Andersons (ANDE) reported a significant increase in second-quarter net income to $56.6 million, or $1.65 per diluted share, compared to $7.9 million a year earlier. This growth was largely driven by record performance in its Renewables segment, which achieved $65 million in pretax …

Earnings Flash (ANDE) The Andersons, Inc. Reports Q2 Revenue $3.10B, vs. FactSet Est of $3.28B

The Andersons, Inc. (ANDE) reported its Q2 revenue at $3.10 billion, falling short of the FactSet estimate of $3.28 billion. This financial update indicates that the company's revenue did not meet analyst expectations for the second quarter. The article is part of an "Earnings …

Grande Group turns to FY26 net loss of $3.54 million; revenue drops 40.6% to $2.58 million

Grande Group reported a net loss of $3.47 million for the fiscal year ended March 31, 2026, a swing from a profit, with diluted loss per share at $0.14. Revenue for the period dropped by 40.6% to $2.58 million. The company's operating loss widened …

Three New Employees Receive Candel Options at $10.01

Candel Therapeutics (Nasdaq: CADL) announced that its Board Compensation Committee granted inducement stock options to three new employees on July 31, 2026. These options allow the employees to purchase an aggregate of 30,800 shares of common stock at an exercise price of $10.01 per …

Tandem Poised to Launch Tubeless Mobi Pump

Tandem Diabetes, a recent entrant in the insulin pump market, is still working to establish itself as a major competitor, despite launching its original t:slim pump in 2012. The company is poised to launch its new tubeless Mobi pump. Morningstar's analysis suggests it will …

Form 144 STANDEX INTERNATIONAL CORP/DE/ For: 3 August By Investing.com

This article announces the filing of Form 144 for STANDEX INTERNATIONAL CORP/DE/ on August 3rd. Form 144 indicates an intent to sell restricted securities, providing transparency regarding potential insider transactions. The brief piece primarily serves as a notification from Investing.com.

Kayne Anderson BDC (KBDC) to Announce Earnings on Monday

Kayne Anderson BDC (KBDC) is set to announce its Q2 2026 earnings on Monday, August 10th, with analysts forecasting earnings per share of $0.39 and revenue of $51.862 million. The company's previous quarter reported an EPS of $0.43, beating estimates, and it currently offers …

Telemark group (ANDG) discloses 720,000-share, 5.3% position in Andersen Group

Telemark Asset Management, Telemark Fund, LP, and Colin S. McNay have jointly disclosed a 5.3% beneficial ownership stake in Andersen Group Inc. (ANDG), amounting to 720,000 shares of its Class A Common Stock. This stake gives them shared voting and dispositive power over the …

SXI shareholder (NYSE: SXI) files notice to sell 50 common shares

Thomas Chorman has filed a notice to sell 50 shares of Standex International Corp/DE/ (NYSE: SXI) common stock through Fidelity Brokerage Services on the NYSE. The aggregate market value of these shares is $15,278.00, with an anticipated sale date of August 3, 2026. Chorman …

Banco Santander Chile’s 90% range close meets a 56.5% Fair Value premium on modest volume

BSAC advanced 3.4% in the latest week and remains close to its 52-week high, but participation stayed below its 13-week norm and the signal read is balanced rather than emphatic.

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Candel Therapeutics, Inc. announced that its Compensation Committee granted stock options to three new employees to purchase an aggregate of 30,800 shares of common stock. These inducement grants, with an exercise price of $10.01 per share, were made under the Company's 2025 Inducement Plan …

Andersons earnings on deck: Can clean fuel credits repeat?

The Andersons Inc. (ANDE) is set to report second-quarter earnings, with analysts focusing on whether the company can sustain its first-quarter performance, which was significantly boosted by clean fuel tax credits and strong ethanol margins. Investors will be watching the ongoing impact of these …

Alexander’s Q2 Income Includes $148M Rego Park I Sale Gain

Alexander's (NYSE: ALX) reported a significant increase in Q2 2026 net income to $155.4 million, primarily driven by a $148.0 million gain from the sale of its Rego Park I property. While this sale boosted net income, the company's Funds From Operations (FFO) showed …

Andersen Group Inc. (NYSE:ANDG) Receives Average Rating of "Moderate Buy" from Analysts

Andersen Group Inc. (NYSE:ANDG) has received an average "Moderate Buy" rating from analysts, with a consensus 12-month price target of $39.00, which is below its current trading price of $47.47. The company recently missed quarterly earnings expectations but saw a 15.7% increase in revenue …

Candel Therapeutics to Present Extended Data from Phase 3 Results of Aglatimagene Besadenovec at ASTRO 2026

Candel Therapeutics announced that an abstract detailing extended data from its Phase 3 clinical trial of aglatimagene besadenovec in localized prostate cancer has been accepted for poster presentation at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting. The presentation, led by Dr. …

Banco Santander Brasil (BSBR) Advances 1.23% to $5.74, Holding Above Key Support - On Balance Volume